• 09/2016: Stephen & Dorothy Zarsky collectively purchased >353K Innate shares on recommendation from their daughter Lauren (Cameron Collins's girlfriend.
  • 04/2017: Innate publicly announced end of clinical study, and final results would be available 08/2017 or 09/2017.
  • 15/05/2017: Chris (Collins) spoke to a US brokerage about transferring to them Innate shares he, his son (Cameron), and his daughter (Caitlin) owned.
  • 16/05/2017: Chris & Cameron each opened accounts at the US brokerage.
  • 21/05/2017: Caitlin opened an account at the US brokerage.
  • 22/05/2017: Chris executed separate forms to transfer his, Caitlin's, and Cameron's shares to the US brokerage.
  • 06/2017: Innate informed their BoD of securities blackout between 05/06/2017 and 11/07/2017 as clinical results release was imminent.
  • 09/06/2017: Cameron's transfer of 5.2M Innate shares is completed. Chris and Caitlin both had problems with their transfer forms, and consequently their shares were not transferred.
  • 09/06/2017: Innate CEO emailed Chris (Collins) and BoD members that delivery date of review would be 22/06/2017.
  • 15/06/2017: Cameron (Collins) opened a new account and used 401(k) fund to purchase >16K more Innate shares.
  • 20/06/2017: Lauren invested in Innate for the first time for >40K shares (in an only 1-day old brokerage account).
  • 20/06/2017: Innate announced FDA cleared their New Drug application.
  • 22/06/2017 - 18:55: Chris & BoD members told top-line results that trial results “pretty clearly indicate ‘clinical failure.’”
  • 22/06/2017 - 19:10: Chris responds to email with incredulity.
  • 22/06/2017 - 19:16: Chris repeatedly tries to contact Cameron & finally reaches him with Lauren present.
  • 22/06/2017 - 19:31: Lauren is checking her brokerage account.
  • 22/06/2017 - 21:17: Cameron & Lauren arrive at her parents' (Zarksy) house.
  • 22/06/2017 - 21:22: Cameron is checking his brokerage account.
  • 22/06/2017 - 21:28: Lauren is checking her brokerage again & unsuccessfully places an order to dump her Innate shares.
  • 22/06/2017 - 21:34: Dorothy calls her brokerage for guidance to sell her shares on the Australian Stock Exchange (ASX).
  • 22/06/2017 - 21:58: Dorothy places her online order to sell all 50K Innate shares, selling minutes thereafter.
  • 22/06/2017 - 22:26: Innate requests ASX to halt trading because Innate received trial results, which apparently disrupted the supposedly confirmed sale by Zarsky wife earlier.
  • 23/06/2017 - 07:42: Cameron ordered an over-the-counter (decentralized) market sale of his Innate shares purchases 15/06/2017.
  • 23/06/2017 07:43: Lauren called her father Stephen.
  • 23/06/2017 07:52: Stephen ordered an OTC sale of his 303K Innate shares.
  • 23/06/2017 09:28: Cameron has arrived at Stephen's place (again), and both log into their brokerage accounts.
  • 23/06/2017 09:30: Both Cameron & Stephen see their earlier orders get successfully executed.
  • 23/06/2017 09:37: Lauren placed order to sell all 46K Innate shares she purchased on 20/06/2017, executed shortly thereafter.
  • 23/06/2017 09ish: Dorothy discovers ASX sale did not go through, and calls her brokerage to place an OTC sale of any remaining Innate shares.
  • 23/06/2017 09:40: Stephen calls friends/relatives to tell them to sell Innate stock. Stephen's brother Eugene placed & completed a sale of all 9K shares he owned.
  • 23/06/2017 09:42: Stephen tells his sister & husband to sell & don't ask why; they were unable (or chose not) to sell.
  • 23/06/2017 09:54: Cameron entered a sale for 100K shares after talking to his father & sells a minute later.
  • 23/06/2017 10:01: Stephen called friend, and friend sold his 15K shares by 10:07.
  • 23/06/2017–26/06/2017: Cameron continued to place 58 different orders to sell off blocks of his >5.2M Innate shares (to minimize share price drop).
    • 09:57: Cameron entered another sale (1) for 100K shares limited at USD$0.51/share or higher.
    • 10:42: Cameron entered another sale (2) for 100K shares for any price, which sells 5 minutes later.
    • 10:49: Cameron cancelled the limited sale (1) and subsequently entered another sale (3) for 100K shares at a lower limited price.
    • 11:32: Cameron speaks to his father for almost 7 minutes.
    • 11:41: Cameron entered another sale (4) for 50K shares at any price, which sells 3 minutes later.
    • 11:44: Cameron entered another sale (5) for 50K shares at a lower limit than that in (3) and cancels sale (3).
    • 12:55–15:02: Cameron repeatedly entered, cancelled, and re-entered orders to sell shares.
    • 15:12: Cameron talks to his father again, and entered a sale (6) for 50K shares limited to USD$0.45/share or higher, which sells 3 minutes later while still on the phone with Chris.
  • 15:19–15:58: Cameron entered 8 more orders that sold 244K shares prior to the OTC market close at 16:00 that Friday (ending at USD$0.54/share).
  • 23/06/2017: Collectively, Cameron, Lauren, Dorothy, Stephen, Eugene, and Stephen's friend sold over 1M shares on the OTC market. Every individual except Cameron was completely divested of their shares by end of day.
  • 26/06/2017 09:08–16:00: Cameron resumed selling shares that Monday (ending at USD$0.45/share). Over 30 sales (of 36 placed), he sold off another 775K shares, totalling 1.39M shares sold at this point.
  • 26/06/2017 09:14: Cameron tipped a friend (who previously purchased Innate shares at Cameron's recommendation) to sell, who then sold all his shares 5 minutes later.
  • 26/06/2017 19:11: Innate Pharma publicly announces the negative results of their clinical trial. The ASX trading halt then lifted.
  • 26/06/2017 19:14: Local newspaper (Buffalo News?) contacted Chris's staff.
  • 26/06/2017 19:24: Chris calls Cameron for 3 minutes.
  • 26/06/2017 19:27: Cameron called his brokerage to enable selling of Innate shares on the ASX.
  • 26/06/2017 20:25: Cameron calls Chris for 2 minutes.
  • 26/06/2017 20:27: Cameron placed a sale order on the ASX for 500K shares limited to AUD$0.03/share or higher, which sells in 2 minutes.
  • 26/06/2017 20:51: Cameron has finally liquidated himself of his remaining 3.825M shares.
  • 27/06/2017: Innate Pharma share prices plummets from $0.45/share to USD$0.0351/share (92% loss).
  • 29/06/2017: The Buffalo News publishes Chris's carefully carved official statement (emphases mine), wherein Cameron is deliberately omitted from the statement wherein individuals did not sell during the stock halt:

    Asked whether Collins' son Cameron, his daughter Caitlin or chief of staff Michael Hook sold any of their Innate Immunotherapeutics stock last Friday – when an unusually large number of shares were traded in the United States – or in the preceding weeks, Collins spokeswoman Sarah Minkel said they had not.

     

    "Neither Chris Collins, Caitlin Collins nor Michael Hook have sold shares prior, during or after Innate's recent stock halt," Minkel said, referring to a halt in trading that was called on the Australian Securities Exchange on Friday. "Cameron Collins has liquidated all his shares after the stock halt was lifted, suffering a substantial financial loss."

Comments